Literature DB >> 16955191

Genital ulcers as initial manifestation of Epstein-Barr virus infection: two new cases and a review of the literature.

Jon Anders Halvorsen1, Trine Brevig, Torkild Aas, Anne Grete Skar, Ellen Margrethe Slevolden, Harald Moi.   

Abstract

Genital ulceration is an uncommon manifestation of primary Epstein-Barr virus (EBV) infection. We present here two cases of genital ulcers probably caused by EBV. The first case is a 12-year-old girl with a genital ulcer appearing before specific EBV serology could identify a primary infection. However, serology was positive 13 days after the ulcer appeared. Polymerase chain reaction for EBV was positive in the biopsy from the ulcer as well. The second case is an 18-year-old female in whom the specific EBV serology was positive 8 days after appearance of the ulcer. The ulcers in both cases healed after 21 days. We reviewed the literature and a total of 26 cases of EBV-associated genital ulcers in females are now published. Median age of the 26 cases is 14.5 years of whom only 6 reports previous sexual contact. Mean healing time for the ulcers is 18 days. Our two cases correspond well with clinical reports of 24 EBV-associated genital ulcers in the literature.

Entities:  

Mesh:

Year:  2006        PMID: 16955191     DOI: 10.2340/00015555-0140

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  11 in total

1.  Genitourinary manifestations of epstein-barr virus infections.

Authors:  Randi Leigh; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

2.  Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.

Authors:  Stefan D Dojcinov; Girish Venkataraman; Stefania Pittaluga; Iwona Wlodarska; Jeffrey A Schrager; Mark Raffeld; Robert K Hills; Elaine S Jaffe
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

3.  Lipschütz's acute vulvar ulcer: a systematic review.

Authors:  Stefano A Vismara; Sebastiano A G Lava; Lisa Kottanattu; Giacomo D Simonetti; Lorenzo Zgraggen; Caterina M Clericetti; Mario G Bianchetti; Gregorio P Milani
Journal:  Eur J Pediatr       Date:  2020-04-15       Impact factor: 3.183

4.  Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant.

Authors:  Luciana Cristina Fagundes Gequelin; Irina N Riediger; Sueli M Nakatani; Alexander W Biondo; Carmem M Bonfim
Journal:  Rev Bras Hematol Hemoter       Date:  2011

5.  Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active australian women.

Authors:  Christopher J McIver; Nikolas Rismanto; Catherine Smith; Zin Wai Naing; Ben Rayner; M Josephine Lusk; Pamela Konecny; Peter A White; William D Rawlinson
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

Review 6.  Laboratory assays for Epstein-Barr virus-related disease.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

7.  Reactive non-sexually related acute genital ulcers associated with COVID-19.

Authors:  Jill M Krapf; Rachel K Casey; Andrew T Goldstein
Journal:  BMJ Case Rep       Date:  2021-05-05

8.  Microbial diversity of genital ulcer disease in men enrolled in a randomized trial of male circumcision in Kisumu, Kenya.

Authors:  Supriya D Mehta; Stefan J Green; Ian Maclean; Hong Hu; Robert C Bailey; Patrick M Gillevet; Greg T Spear
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  Simultaneous genital ulcer and meningitis: a case of EBV infection.

Authors:  Hassan Rahhal; Jairo Tavares Nunes; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2016-06-30

10.  A case of COVID-19-related acute genital ulceration in a male.

Authors:  Abdurrahman Kaya; Sibel Yıldız Kaya
Journal:  Int J STD AIDS       Date:  2022-03-25       Impact factor: 1.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.